Area of research
Molecular Biology · Cellular and Molecular Neuroscience
Research interest
Research interests include Neuroscience and Neuropharmacology Research, Wnt/β-catenin signaling in development and cancer, Genetics and Neurodevelopmental Disorders, and Bipolar Disorder and Treatment.
Targeting the Adaptive Immune System in Depression: Focus on T Helper 17 Cells
Comparison of inflammatory and behavioral responses to chronic stress in female and male mice
Toll-like receptor 2 (TLR2)-deficiency impairs male mouse recovery from a depression-like state
(+)-Naloxone blocks Toll-like receptor 4 to ameliorate deleterious effects of stress on male mouse behaviors
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
Distinct characteristics of hippocampal pathogenic TH17 cells in a mouse model of depression
Intranasal siRNA administration reveals IGF2 deficiency contributes to impaired cognition in Fragile X syndrome mice
Stress-induced neuroinflammation is mediated by GSK3-dependent TLR4 signaling that promotes susceptibility to depression-like behavior
Stressed and Inflamed, Can GSK3 Be Blamed?
Ketamine‐induced inhibition of glycogen synthase kinase‐3 contributes to the augmentation of α‐amino‐3‐hydroxy‐5‐methylisoxazole‐4‐propionic acid (AMPA) receptor signaling
GSK3β isoform‐selective regulation of depression, memory and hippocampal cell proliferation
Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome
Up-regulation of insulin-like growth factor 2 by ketamine requires glycogen synthase kinase-3 inhibition
Ketamine up-regulates a cluster of intronic miRNAs within the serotonin receptor 2C gene by inhibiting glycogen synthase kinase-3
A pre-conditioning stress accelerates increases in mouse plasma inflammatory cytokines induced by stress
Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases
Inflammation and lithium: clues to mechanisms contributing to suicide-linked traits
Astrocytes Modulate the Polarization of CD4+ T Cells to Th1 Cells
Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments
Glycogen Synthase Kinase-3 Inhibitors Reverse Deficits in Long-term Potentiation and Cognition in Fragile X Mice
Regulation of Th1 Cells and Experimental Autoimmune Encephalomyelitis by Glycogen Synthase Kinase-3
DDX3 regulates DNA damage-induced apoptosis and p53 stabilization
Lithium treatment alleviates impaired cognition in a mouse model of fragile X syndrome
Impaired translocation and activation of mitochondrial Akt1 mitigated mitochondrial oxidative phosphorylation Complex V activity in diabetic myocardium
Inflammatory T Helper 17 Cells Promote Depression-like Behavior in Mice
Activation of the ATM-Snail pathway promotes breast cancer metastasis
Inactivation of the Enzyme GSK3α by the Kinase IKKi Promotes AKT-mTOR Signaling Pathway that Mediates Interleukin-1-Induced Th17 Cell Maintenance
Disruption of circadian rhythmicity and suprachiasmatic action potential frequency in a mouse model with constitutive activation of glycogen synthase kinase 3
Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice